Literature DB >> 17079635

Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic duration.

Cíntia Maria Saia Cereda1, Giovana Bruschini Brunetto, Daniele Ribeiro de Araújo, Eneida de Paula.   

Abstract

PURPOSE: A laboratory investigation was undertaken to compare the in vivo antinociceptive effects of 2% liposomal formulations of prilocaine (PLC), lidocaine (LDC) and mepivacaine (MVC) compared to plain solutions of each of these three local anesthetics.
METHODS: Large unilamellar vesicles were prepared by extrusion (400 nm), at pH 7.4. The membrane/water partition coefficients were obtained from encapsulation efficiency values, after incorporation of each local anesthetic to the vesicles. The anesthetic effect of each liposomal formulation was compared to the respective local anesthetic solution in water, using the infraorbital nerve-blockade test, in rats.
RESULTS: The partition coefficients were: 57 for PLC, 114 for LDC and 93 for MVC. In vivo results showed that local anesthetic-free liposomes, used as control, had no analgesic effect. In contrast, the encapsulated formulations induced increased intensities of total anesthetic effect (35.3%, 26.1% and 57.1%) and time for recovery (percentage increases of 30%, 23.1% and 56%), respectively, for PLC, LDC and MVC when compared to the plain solutions (P < 0.01).
CONCLUSIONS: These results indicate that liposomes provide effective drug-delivery systems for intermediate-duration local anesthetics. Mepivacaine was affected to the greatest extent, while LDC benefited least from liposome encapsulation, possibly due to greater vasodilatory properties of LDC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079635

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  8 in total

Review 1.  Safety and efficacy concerns of modern strategies of local anesthetics delivery.

Authors:  Mingxin Ji; Guoliang Liu; Yunfeng Cui; Peng Zhao
Journal:  3 Biotech       Date:  2020-07-06       Impact factor: 2.406

2.  A sumatriptan coarse-grained model to explore different environments: interplay with experimental techniques.

Authors:  Irene Wood; Juan M R Albano; Pedro L O Filho; Veronica Muniz Couto; Marcelo A de Farias; Rodrigo V Portugal; Eneida de Paula; Cristiano L P Oliveira; Monica Pickholz
Journal:  Eur Biophys J       Date:  2018-01-29       Impact factor: 1.733

3.  Comparison of antinociceptive effects of plain lidocaine versus lidocaine complexed with hydroxypropyl-β-cyclodextrin in animal models of acute and persistent orofacial pain.

Authors:  Stéphani Batista de Oliveira; Erika Ivanna Araya; Eder Gambeta; Luiz Eduardo Nunes Ferreira; Michele Franz-Montan; Rafaela Franco Claudino; Juliana Geremias Chichorro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-06       Impact factor: 3.000

4.  Prolonged duration local anesthesia with minimal toxicity.

Authors:  Hila Epstein-Barash; Iris Shichor; Albert H Kwon; Sherwood Hall; Michael W Lawlor; Robert Langer; Daniel S Kohane
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-13       Impact factor: 11.205

5.  Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.

Authors:  Yongjian Yang; Dahai Qiu; Yajun Liu; Lei Chao
Journal:  Drug Des Devel Ther       Date:  2019-09-18       Impact factor: 4.162

6.  Bupivacaine in alginate and chitosan nanoparticles: an in vivo evaluation of efficacy, pharmacokinetics, and local toxicity.

Authors:  Cíntia Maria Saia Cereda; Daniel Sebbe Mecatti; Juliana Zampoli Boava Papini; Diego Valério Bueno; Michelle Franz-Montan; Thalita Rocha; José Pedrazzoli Júnior; Eneida de Paula; Daniele Ribeiro de Araújo; Renato Grillo; Leonardo Fernandes Fraceto; Silvana Aparecida Calafatti; Giovana Radomille Tofoli
Journal:  J Pain Res       Date:  2018-04-06       Impact factor: 3.133

7.  Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm.

Authors:  Andreia Borges Scriboni; Verônica Muniz Couto; Lígia Nunes de Morais Ribeiro; Irlan Almeida Freires; Francisco Carlos Groppo; Eneida de Paula; Michelle Franz-Montan; Karina Cogo-Müller
Journal:  Front Pharmacol       Date:  2019-11-29       Impact factor: 5.810

8.  Improvement of Butamben Anesthetic Efficacy by the Development of Deformable Liposomes Bearing the Drug as Cyclodextrin Complex.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri; Giulia Nerli; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Natascia Mennini
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.